ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

 

ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy
Avatar

HMGCLL1 Is a Predictive Germline Biomarker for Deep Molecular Response to Imatinib Therapy in Chronic Myeloid Leukemia

By ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy FEATURING Dennis Kim
By ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy FEATURING Dennis Kim
0 views
January 18, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray

Featured Video

24:08
Indy Hematology Review

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Feat. A. Tefferi
Scientific Session 4: Mechanisms of Resistance
11:54
ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

The Association of Transposable Elements with Chronic Myeloid Leukem…

Feat. J. Koblihova
20:46
ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

Resistance and Progression to TKI: Not Just Mutations

Feat. J. Radich
12:16
ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

HMGCLL1 Is a Predictive Germline Biomarker for Deep Molecular Respon…

Feat. D. Kim